Gyre Therapeutics, Inc.
GYRENasdaqCIK 1124105HealthcareFiscal year ends Dec 31
Reports and events: 435 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2220:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-040506 |
| 2026-09-0113:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-035189 |
| 2026-08-2613:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-034401 |
| 2026-08-0721:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-340448 |
| 2026-08-0712:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-339223 |
| 2026-07-1620:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-028716 |
| 2026-07-1521:09 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-028564 |
| 2026-06-1610:30 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-025324 |
| 2026-06-0210:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-023625 |
| 2026-05-1421:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-021360 |
| 2026-05-1221:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-020845 |
| 2026-05-0820:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-214676 |
| 2026-05-0710:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-019395 |
| 2026-05-0601:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-019388 |
| 2026-05-0600:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-019380 |
| 2026-05-0700:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209789 |
| 2026-05-0413:12 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-018716 |
| 2026-04-2720:30 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001140361-26-017124 |
| 2026-04-1712:55 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-015307 |
| 2026-03-2311:51 ET | 8-K | 8.01 Other events | 0001140361-26-010654 |
| 2026-03-1320:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-106251 |
| 2026-03-1210:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-26-009115 |
| 2026-03-1200:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102700 |
| 2026-03-0214:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-007249 |
| 2026-01-0512:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000253 |
| 2025-11-0721:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272383 |
| 2025-11-0702:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-270524 |
| 2025-09-1013:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-034506 |
| 2025-08-2211:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-032295 |
| 2025-08-1121:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106644 |
| 2025-08-1120:00 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106525 |
| 2025-06-0623:27 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-021612 |
| 2025-05-2320:46 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-020353 |
| 2025-05-2220:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-020157 |
| 2025-05-0920:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068089 |
| 2025-05-0900:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067452 |
| 2025-04-2811:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-015880 |
| 2025-04-2121:23 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001140361-25-014779 |
| 2025-03-1720:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040279 |
| 2025-03-1720:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040232 |
| 2025-02-1811:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-004957 |
| 2025-01-0612:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000292 |
| 2024-11-2721:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-24-047980 |
| 2024-11-1321:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126306 |
| 2024-11-1301:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125869 |
| 2024-09-0612:31 ET | SC 13D | Ownership report, active investor | 0001140361-24-040318 |
| 2024-09-0612:15 ET | SC 13D | Ownership report, active investor | 0001140361-24-040313 |
| 2024-08-1320:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096159 |
| 2024-08-1301:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095687 |
| 2024-08-0820:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-036404 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.